Tag Archives: statins
September 2007 Br J Cardiol 2007;14:242-44
Rhabdomyolysis and acute renal failure due to simvastatin and amiodarone
Haroon Siddique, Maria Mushkbar, Adrian Walker, John Scarpello
Introduction Statins are increasingly used for primary and secondary prevention of cardiovascular disease, and in the UK simvastatin is now available as an ‘over-the-counter’ drug without prescription. Rhabdomyolysis is a rare and potentially life-threatening complication of statin therapy and with the wider use of statins there is an increased probability of drug interactions, which may increase the incidence of myopathy and rhabdomyolysis. Early recognition is essential to prevent serious consequences. We report a case of rhabdomyolysis complicated by acute renal failure associated with the concomitant use of high-dose simvastatin and a
November 2006 Br J Cardiol 2006;13:367-9
The impact of the new GP contract on measurement of lipids and use of statins in the over 80s with coronary heart disease
Samira Siddiqui, Chris Isles, Ewan Bell, Alan Begg
No content available
May 2006 Br J Cardiol 2006;13:196-202
Cost-effectiveness of rosuvastatin, atorvastatin, simvastatin, pravastatin and fluvastatin for the primary prevention of CHD in the UK
Andrew Davies, John Hutton, John O'donnell, Sarah Kingslake
No content available
May 2006 Br J Cardiol 2006;13:205-208
Do fibrates offer special benefits in treating diabetic dyslipidaemia? Lessons from FIELD
Hugh F McIntyre
No content available
September 2005 Br J Cardiol 2005;12:397-400
Statin prescribing: is the reality meeting the expectations of primary care?
Adrian JB Brady, John Norrie, Ian Ford
No content available
September 2005 Br J Cardiol 2005;12:379-86
New approaches to the management of dyslipidaemia
Lena M Izzat, Philip Avery
No content available
November 2004 Br J Cardiol 2004;11:487-91
Statins in primary care: bridging the treatment gap
Rubin Minhas
No content available
November 2004 Br J Cardiol 2004;11:455-60
Should all diabetic patients receive a statin? Results from recent trials
Gillian Marshall, Claire McDougall, Adrian JB Brady, Miles Fisher
No content available
November 2004 Br J Cardiol 2004;11:449-54
Statin safety in perspective – maximising the risk:benefit
Marc Evans
No content available
July 2004 Br J Cardiol 2004;11:282-6
The National Cholesterol Education Program III scoring system for CHD risk estimation cannot be used with European recommendations
Navneet Singh, See Kwok, C Jeffrey Seneviratne, Michael France, Paul Durrington
No content available
For healthcare professionals only
